The diagnostic performance of CA125 for the detection of ovarian and non-ovarian cancer in primary care: A population-based cohort study

BACKGROUND: The serum biomarker cancer antigen 125 (CA125) is widely used as an investigation for possible ovarian cancer in symptomatic women presenting to primary care. However, its diagnostic performance in this setting is unknown. We evaluated the performance of CA125 in primary care for the det...

Descripción completa

Detalles Bibliográficos
Autores principales: Funston, Garth, Hamilton, Willie, Abel, Gary, Crosbie, Emma J., Rous, Brian, Walter, Fiona M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592785/
https://www.ncbi.nlm.nih.gov/pubmed/33112854
http://dx.doi.org/10.1371/journal.pmed.1003295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592785/
https://www.ncbi.nlm.nih.gov/pubmed/33112854
http://dx.doi.org/10.1371/journal.pmed.1003295

Ejemplares similares